{{scheme.chgp}}%
{{scheme.chgp}}%
No Matches Found
{{scheme.chgp}}%
No Matches Found
No Matches Found
AEON Biopharma, Inc.
Is AEON Biopharma, Inc. technically bullish or bearish?
As of June 17, 2025, AEON Biopharma, Inc. shows a mildly bearish trend due to bearish daily moving averages and Bollinger Bands, despite some mildly bullish signals from the MACD and mixed views from Dow Theory.
What does AEON Biopharma, Inc. do?
AEON Biopharma, Inc. is a micro-cap company in the Pharmaceuticals & Biotechnology industry, reporting a net profit of $9 million for Q1 2025 and a market cap of $8.65 million. It has a negative P/E ratio, no dividend yield, and a high return on equity of 855.59%.
How big is AEON Biopharma, Inc.?
As of Jun 18, AEON Biopharma, Inc. has a market capitalization of 8.65 million, categorizing it as a Micro Cap company, with reported net sales of 0.00 million and a net profit of 169.12 million over the latest four quarters. The company has shareholder's funds of -28.57 million and total assets of 3.14 million as of Dec 24.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
